Fabrication of novel vesicles of triptolide for antirheumatoid activity with reduced toxicity in vitro and in vivo [Corrigendum]
Zhang L, Wang TT, Li Q, et al. Int J Nanomedicine. 2016;11:2663–2673.
Following a review of their data post-publication, the authors found errors in the kidney and PPT group image used for Figure 7 on page 2671 and the spleen control and PP group images and liver PP and PPT group images used for Figure 8 on page 2671. For accuracy and experimental integrity these images have been corrected, with no impact to the conclusions of the study. The authors apologize for these errors.
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.